261 related articles for article (PubMed ID: 8222382)
1. Antiplatelet therapy in the treatment of cerebrovascular disease.
Couch JR
Clin Cardiol; 1993 Oct; 16(10):703-10. PubMed ID: 8222382
[TBL] [Abstract][Full Text] [Related]
2. Antiplatelet agents in the prevention of cardiovascular morbidity and mortality in older patients with vascular disease.
Aronow WS
Drugs Aging; 1999 Aug; 15(2):91-101. PubMed ID: 10495069
[TBL] [Abstract][Full Text] [Related]
3. Antiplatelet therapy in the prevention of ischaemic stroke.
Verry M; Panak E; Cazenave JP
Nouv Rev Fr Hematol (1978); 1994 Jun; 36(3):213-28. PubMed ID: 7971242
[TBL] [Abstract][Full Text] [Related]
4. Antiplatelet therapy in the prevention of stroke.
Easton JD
Drugs; 1991; 42 Suppl 5():39-50. PubMed ID: 1726215
[TBL] [Abstract][Full Text] [Related]
5. Antiplatelet therapy in the treatment of atherothrombotic disease: considering the evidence.
Aronow WS
Geriatrics; 2007 Apr; 62(4):12-24. PubMed ID: 17408314
[TBL] [Abstract][Full Text] [Related]
6. Update on aspirin in the treatment and prevention of cardiovascular disease.
Hennekens CH
Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of ticlopidine and aspirin for prevention of reversible cerebrovascular ischemic events. The Ticlopidine Aspirin Stroke Study.
Bellavance A
Stroke; 1993 Oct; 24(10):1452-7. PubMed ID: 8378945
[TBL] [Abstract][Full Text] [Related]
8. Antiplatelet treatment for prevention of cerebrovascular events in patients with vascular diseases: a systematic review and meta-analysis.
Gouya G; Arrich J; Wolzt M; Huber K; Verheugt FW; Gurbel PA; Pirker-Kees A; Siller-Matula JM
Stroke; 2014 Feb; 45(2):492-503. PubMed ID: 24368560
[TBL] [Abstract][Full Text] [Related]
9. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
De Schryver EL; Algra A; van Gijn J
Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415
[TBL] [Abstract][Full Text] [Related]
10. Clinical considerations in selecting antiplatelet therapy in cerebrovascular disease.
Harbison JW
Am J Health Syst Pharm; 1998 Oct; 55(19 Suppl 1):S17-20. PubMed ID: 9784798
[TBL] [Abstract][Full Text] [Related]
11. Clopidogrel for cerebrovascular prevention.
Paciaroni M; Bogousslavsky J
Cerebrovasc Dis; 1999; 9(5):253-60. PubMed ID: 10473907
[TBL] [Abstract][Full Text] [Related]
12. Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease.
Tran H; Anand SS
JAMA; 2004 Oct; 292(15):1867-74. PubMed ID: 15494585
[TBL] [Abstract][Full Text] [Related]
13. Use of antiplatelet medication for prevention of myocardial infarction and stroke.
Rakel RE
Heart Dis Stroke; 1992; 1(1):2-3. PubMed ID: 1344081
[TBL] [Abstract][Full Text] [Related]
14. Stroke prevention in women: role of aspirin versus ticlopidine.
Hershey LA
Am J Med; 1991 Sep; 91(3):288-92. PubMed ID: 1832517
[TBL] [Abstract][Full Text] [Related]
15. Thienopyridine derivatives (ticlopidine, clopidogrel) versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients.
Hankey GJ; Sudlow CL; Dunbabin DW
Cochrane Database Syst Rev; 2000; (2):CD001246. PubMed ID: 10796426
[TBL] [Abstract][Full Text] [Related]
16. What have we learned from recent antiplatelet trials?
Easton JD
Neurology; 1998 Sep; 51(3 Suppl 3):S36-8. PubMed ID: 9744831
[TBL] [Abstract][Full Text] [Related]
17. Aspirin and ticlopidine for prevention of recurrent stroke in black patients: a randomized trial.
Gorelick PB; Richardson D; Kelly M; Ruland S; Hung E; Harris Y; Kittner S; Leurgans S;
JAMA; 2003 Jun; 289(22):2947-57. PubMed ID: 12799402
[TBL] [Abstract][Full Text] [Related]
18. Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.
BMJ; 1994 Jan; 308(6921):81-106. PubMed ID: 8298418
[TBL] [Abstract][Full Text] [Related]
19. Ticlopidine: a new antiplatelet agent for cerebrovascular disease.
Robert S; Miller AJ; Fagan SC
Pharmacotherapy; 1991; 11(4):317-22; discussion 322-5. PubMed ID: 1923914
[TBL] [Abstract][Full Text] [Related]
20. Review of antiplatelet therapy in secondary prevention of cerebrovascular events: a need for direct comparisons between antiplatelet agents.
Jamieson DG; Parekh A; Ezekowitz MD
J Cardiovasc Pharmacol Ther; 2005 Sep; 10(3):153-61. PubMed ID: 16211203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
